Park, A., Yang, Y., Lee, Y., Kim, M. S., Park, Y., Jung, H., . . . Yoon, S. R. (2019). Indoleamine-2,3-Dioxygenase in Thyroid Cancer Cells Suppresses Natural Killer Cell Function by Inhibiting NKG2D and NKp46 Expression via STAT Signaling Pathways. J Clin Med.
シカゴスタイル引用形Park, Arum, et al. "Indoleamine-2,3-Dioxygenase in Thyroid Cancer Cells Suppresses Natural Killer Cell Function By Inhibiting NKG2D and NKp46 Expression Via STAT Signaling Pathways." J Clin Med 2019.
MLA引用形式Park, Arum, et al. "Indoleamine-2,3-Dioxygenase in Thyroid Cancer Cells Suppresses Natural Killer Cell Function By Inhibiting NKG2D and NKp46 Expression Via STAT Signaling Pathways." J Clin Med 2019.
警告: この引用は必ずしも正確ではありません.